Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients
Though an effective treatment, Lu-177 radioligland therapy it is not without side effects, some of which can be severe.
FDA sued over ‘reckless and arbitrary’ semaglutide decision
The Outsourcing Facilities Association, a Texas-based trade group, is alleging that supply issues still remain for Ozempic and Wegovy. The group believes the FDA has ignored those issues.
Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities
The acquisition helps Teleflex expand its interventional and vascular portfolios. Biotronik, meanwhile, is shifting its focus toward implantable devices and digital healthcare.
Adaptable AI system detects subtle changes in imaging over time, has potential for multiple clinical settings
The Learning-based Inference of Longitudinal imAge Changes, or LILAC, system harnesses the power of machine learning to review medical images that have been collected over a prolonged period of time.
FDA clears Google smartwatch tech that calls 911 when a user’s heart stops
Google worked with AI specialists, cardiologists and even stunt performers to develop its new smartwatch feature.

High meat protein diets increase CVD risk by 60%

Individuals who consume large amounts of meat protein experience a 60 percent increase in cardiovascular disease (CVD), according to research published in the International Journal of Epidemiology on April 3.

TAVR better, cheaper than SAVR for patients with COPD

Transcatheter aortic valve replacement (TAVR) was associated with lower in-hospital mortality and significantly fewer respiratory complications than surgery for patients with chronic obstructive pulmonary disease (COPD), according to study published April 1 in the Journal of the American Heart Association.

FDA approves septal occluder for PFO closure to prevent recurrent stroke

Already approved for the purpose its name implies, the Gore Cardioform septal occluder has also received the FDA’s OK for patent foramen ovale (PFO) closure to prevent recurrent ischemic stroke.

Genetic testing to inform antiplatelet choice reduces adverse events post-PCI

A genetic test to inform decisions about what antiplatelet to use following percutaneous coronary intervention (PCI) significantly reduced the number of major cardiovascular or cerebrovascular events in a single-center study published in Circulation: Genomic and Precision Medicine.

Outcome Health, WomenHeart partner to bring CV info to minorities

Chicago-based Outcome Health announced a collaboration with advocacy group WomenHeart: The National Coalition for Women with Heart Disease, to “provide actionable educational information” to cardiology providers across Outcome Health’s network of providers.

Abiomed adds optical sensor, SmartAssist technology to FDA approval for Impella CP

Abiomed announced April 2 its Impella CP heart pump has received expanded FDA premarket approval for its SmartAssist technology. SmartAssist utilizes an optical sensor to inform exact positioning for the device and provide data on left ventricular pressure, end-diastolic pressure and cardiac power output.

New study finds no link between heart failure, cancer

Heart failure was not associated with an increased risk of cancer in a study of almost 30,000 men despite previous reports linking the two conditions.

AFib ablation strategies for ‘normal’ hearts also work for CHD survivors

Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.

Clinical

Simple CT metric predicts treatment-induced kidney impairment in prostate cancer patients

FDA sued over ‘reckless and arbitrary’ semaglutide decision

Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities

Adaptable AI system detects subtle changes in imaging over time, has potential for multiple clinical settings

FDA clears Google smartwatch tech that calls 911 when a user’s heart stops